205 related articles for article (PubMed ID: 18832750)
1. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels.
Korpisalo P; Karvinen H; Rissanen TT; Kilpijoki J; Marjomäki V; Baluk P; McDonald DM; Cao Y; Eriksson U; Alitalo K; Ylä-Herttuala S
Circ Res; 2008 Nov; 103(10):1092-9. PubMed ID: 18832750
[TBL] [Abstract][Full Text] [Related]
2. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
[TBL] [Abstract][Full Text] [Related]
3. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
4. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral Gene Transfer of Gremlin Modulates Vascular Endothelial Growth Factor-A-Induced Angiogenesis in Porcine Myocardium.
Pajula JJ; Halonen PJ; Hätinen OP; Ylä-Herttuala S; Nurro J
Hum Gene Ther; 2020 Feb; 31(3-4):211-218. PubMed ID: 31884825
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle.
Kholová I; Koota S; Kaskenpää N; Leppänen P; Närväinen J; Kavec M; Rissanen TT; Hazes T; Korpisalo P; Gröhn O; Ylä-Herttuala S
Hum Gene Ther; 2007 Mar; 18(3):232-44. PubMed ID: 17362136
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
[TBL] [Abstract][Full Text] [Related]
8. Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer.
Pajusola K; Künnapuu J; Vuorikoski S; Soronen J; André H; Pereira T; Korpisalo P; Ylä-Herttuala S; Poellinger L; Alitalo K
FASEB J; 2005 Aug; 19(10):1365-7. PubMed ID: 15958522
[TBL] [Abstract][Full Text] [Related]
9. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.
Onimaru M; Yonemitsu Y; Fujii T; Tanii M; Nakano T; Nakagawa K; Kohno R; Hasegawa M; Nishikawa S; Sueishi K
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1685-96. PubMed ID: 19734356
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
[TBL] [Abstract][Full Text] [Related]
12. Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.
Darden J; Payne LB; Zhao H; Chappell JC
Angiogenesis; 2019 Feb; 22(1):167-183. PubMed ID: 30238211
[TBL] [Abstract][Full Text] [Related]
13. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P
J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363
[TBL] [Abstract][Full Text] [Related]
14. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
[TBL] [Abstract][Full Text] [Related]
15. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.
Benjamin LE; Hemo I; Keshet E
Development; 1998 May; 125(9):1591-8. PubMed ID: 9521897
[TBL] [Abstract][Full Text] [Related]
16. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
[TBL] [Abstract][Full Text] [Related]
18. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
19. Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle via reduced eNOS activity.
Nieminen T; Toivanen PI; Laakkonen JP; Heikura T; Kaikkonen MU; Airenne KJ; Ylä-Herttuala S
Cardiovasc Res; 2015 Jul; 107(2):267-76. PubMed ID: 26002231
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.
Ledford KJ; Murphy N; Zeigler F; Bartel RL; Tubo R
Stem Cell Res Ther; 2015 Mar; 6(1):25. PubMed ID: 25889271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
